American International Group, Inc. Absci Corp Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$1.58 - $3.41 $799 - $1,725	506 Added 2.03%	25,422 $44,000
Q4 2022 Feb 10, 2023	SELL	$2.0 - $3.58 $180 - $322	-90 Reduced 0.36%	24,916 $52,000
Q3 2022 Nov 14, 2022	BUY	$2.95 - $4.83 $1,038 - $1,700	352 Added 1.43%	25,006 $78,000
Q2 2022 Aug 12, 2022	SELL	$3.13 - $8.83 $9,227 - $26,030	-2,948 Reduced 10.68%	24,654 $82,000
Q1 2022 May 13, 2022	BUY	$5.87 - $9.46 $118,738 - $191,356	20,228 Added 274.32%	27,602 $233,000
Q4 2021 Feb 11, 2022	SELL	$7.88 - $18.03 $1,741 - $3,984	-221 Reduced 2.91%	7,374 $60,000
Q3 2021 Nov 12, 2021	BUY	$10.37 - $30.29 $78,760 - $230,052	7,595 New	7,595 $88,000

139

61.8M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $434M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.